Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1021-1030 of 9364

Page
per page
  1. Ondansetron HCl
    A5166 Ondansetron HCl
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
  2. Dexrazoxane HCl (ICRF-187, ADR-529)
    A1602 Dexrazoxane HCl (ICRF-187, ADR-529)
    Target: Topoisomerases
    Summary: Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent
      insoluble in EtOH; ≥15.24 mg/mL
  3. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  4. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  5. Prazosin HCl
    A5318 Prazosin HCl
    Summary: α1 and α2B-adrenoceptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥6.99 mg/mL
  6. Candesartan
    A5932 Candesartan
    Summary: Angiotensin II receptor 1 (AT1) antagonist
      insoluble in H2O; ≥14.65 mg/mL
  7. Perindopril Erbumine
    A8019 Perindopril Erbumine
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE inhibitor
      ≥111.4 mg/mL
  8. Tranilast
    A5375 Tranilast
    Summary: Angiogenesis inhibitor
      ≥32.7 mg/mL
  9. Ranolazine 2HCl
    A5300 Ranolazine 2HCl
    Summary: Partial fatty acid oxidation inhibitor
      ≥20.25 mg/mL
  10. Zonisamide
    A5354 Zonisamide
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: Antiepileptic with anticonvulsant and mechanistic effect
      insoluble in H2O; ≥8.35 mg/mL

Items 1021-1030 of 9364

Page
per page